Article info
PDFPrevention
Randomised controlled trial
Menopausal hormone therapy has risks and benefits during the intervention and poststopping phase
- Correspondence to : Dr Michelle P Warren, Department of Obstetrics and Gynecology, Columbia University Medical Center, 630 West 168th Street; New York, NY 10032, USA; mpw1{at}columbia.edu
Citation
Menopausal hormone therapy has risks and benefits during the intervention and poststopping phase
Publication history
- First published February 3, 2014.
Online issue publication
January 14, 2023
Article Versions
- Previous version (14 January 2023).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions